Key facts
- It has raised $4.3M across 1 recorded rounds; the latest was Seed Round ($4.1M) in Mar 2026.
- Notable investors include University of California, CONNECT (San Diego), AFCR, ALMA Life Sciences, Bootstrap Venture Partners — 12 tracked in total.
- Acurion has filed 1 Form D with the SEC, most recently Apr 2026 ($4.1M sold to 36 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Acurion
Funding rounds
1 roundsAbout Acurion
Operator of an artificial intelligence-driven digital pathology intended for oncology diagnostics. The company utilizes advanced image analysis, molecular profiling, and biomarker detection technologies to analyze routine pathology slides, enabling oncologists and healthcare providers to deliver timely, accurate, and equitable cancer care.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2021
- Employees
- 9
- Website
- acurionhealth.com/
- Ownership
- Privately Held (backing)
Acurion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Acurion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Acurion in its N-PORT filings yet. We sweep new filings monthly.